Episode
Episode 106 - Dr. Isaac Eliaz - Sepsis: The Condition Killing More People Than Cancer That Nobody Talks About
- Podcast
- This Healthy Life
- Published
- Jun 2, 2026
- Duration seconds
- 2564
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/this-healthy-life-7301694/episodes/episode-106-dr-isaac-eliaz-sepsis-the-condition-killing-more-people-than-cancer-that-nobody-talks-about/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/this-healthy-life-7301694/episode-106-dr-isaac-eliaz-sepsis-the-condition-killing-more-people-than-cancer-that-nobody-talks-about.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
MEET THE GUEST Isaac Eliaz, MD, MS, LAc, has been a pioneer in integrative medicine since the early 1980s, focusing on cancer, immune health, detoxification, and mind-body medicine. He’s a respected clinician, researcher, author, and educator, and the author of The Survival Paradox. He is the founder and Medical Director of Amitabha Medical Clinic and Healing Center, and founder and CEO of Eliaz Therapeutics, a medical device company focused on transforming the treatment of sepsis and other life-threatening diseases. WHAT WE TALK ABOUT What sepsis really is and why it is often misunderstood as just an infection. Why sepsis is the leading cause of death globally and how it progresses in the body. The difference between a typical infection and when it becomes life-threatening sepsis. Early warning signs of sepsis and when to seek urgent medical care. How immune overreaction, not just infection, drives the severity of sepsis. The connection between sepsis, inflammation, mitochondrial dysfunction, and chronic disease. Leaky gut, the microbiome, and how barrier breakdown contributes to systemic inflammation. What galectin-3 is and its role as a key driver of inflammation and disease progression. How galectin-3 influences conditions like cancer, fibrosis, and autoimmune disease. Apheresis explained: what it is, how it works, and its role in removing inflammatory compounds. Dr. Eliaz’s research on targeting galectin-3 as a potential breakthrough treatment for sepsis. Long-term effects of sepsis, including organ damage and chronic illness. Recovery after sepsis and how to support the body’s healing process. The future of sepsis treatment, including clinical trials and emerging therapies. EPISODE RESOURCES Eliaz Therapeutics Eliaz Therapeutics is developing XGal-3®, an FDA Brea…